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Abstract
Background: The susceptibility of hypertrophied myocardium to ischemia-reperfusion injury is associated with
increased risk of postoperative arrhythmias. We investigate the effects of ischemic preconditioning (IP) on post-
ischemic reperfusion arrhythmias in hypertrophic rabbit hearts.
Methods: Thirty-three rabbit models of myocardial hypertrophy were randomly divided into three groups of 11
each: non-ischemia-reperfusion group (group A), ischemia-reperfusion group (group B), and ischemic
preconditioning group (group C). Another ten healthy rabbits with normal myocardium served as the healthy
control group. Rabbit models of myocardial hypertrophy were induced by abdominal aortic banding. Surface
electrocardiogram (ECG) was recorded and Curtis-Ravingerova score was used for arrhythmia quantification.
Connexin 43 (Cx43) expression was assessed by immunohistochemistry.
Results: Ratios of heart weight to body weight and left ventricular weight to body weight increase significantly in
the three groups compared with the healthy control group (p < 0.05). Arrhythmia incidence in group C is
significantly lower than group B (p < 0.05). Curtis-Ravingerova score in group C is lower than group B (p < 0.05).
Cx43 expression area in group A is smaller by comparison with the healthy control group (p < 0.05). Cx43
expression area and fluorescence intensity in group B are reduced by 60.9% and 23.9%, respectively, compared
with group A (p < 0.05). In group C, Cx43 expression area increases by 32.5% compared with group B (p < 0.05),
and decreases by 54.8% compared with group A (p < 0.05).
Conclusions: The incidence of ischemia/reperfusion-induced arrhythmias in hypertrophic rabbit hearts decreases
after IP, which plays an important protecting role on the electrophysiology of hypertrophied myocardium by up-
regulating the expression of Cx43.
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Background
Various degrees of myocardial injury are present in hyper-
trophic hearts of patients undergoing open heart surgery.
The hypertrophied myocardium differs from normal myo-
cardium in myocyte architecture and myocardial blood
supply. The decline of tolerance to ischemia-reperfusion
injury of hypertrophied myocardium, due to pathological
changes in cellular architecture and metabolism, is one of
the causes of post-ischemic reperfusion arrhythmias. For
the hypertrophied heart with a concomitant anomaly such
as aortic valve stenosis, the vulnerability to arrhythmias
increases with (1) a preoperative history of cardiac insuffi-
ciency and (2) insults of intraoperative hypothermic cardi-
oplegia and ischemia/reperfusion.
The challenge in the management of postoperative
arrhythmias lies in masterin gt h ec o m p l e x i t yo fp a t h o -
physiology of arrhythmias. The derangement in the pat-
terns of impulse conduction along the myocardium,
especially in hypertrophied heart, is a factor contributing
to the occurrence of postoperative arrhythmias. Peters et
al. [1] showed that compared with normal adult human
working ventricular myocardium, the surface area of gap
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hearts subject to chronic hypertrophy and ischemia,
which may induce abnormal impulse propagation in
these hearts. Danik et al. [2] pointed out that Connexin
43 (Cx43), the predominant ventricular gap junction
protein, is critical for maintaining normal cardiac elec-
trical conduction, and its absence in the mouse heart
results in sudden arrhythmic death. They insisted that
the growing recognition that gap junction remodeling is
a major contributor to the arrhythmogenic substrate in
the diseased heart and suggested that uncoupling as a
result of diminished Cx43 expression plays a mechanis-
tic role in the formation of a highly arrhythmogenic
substrate. Li et al. [3] found that decreasing gap junc-
tion plaque size was associated with increasing arrhyth-
mogenecity in the absence of cardiomyopathy. And, N-
cadherin function may be perturbed in diseased myocar-
dium leading to altered gap junction organization thus
generating an arrhythmogenic substrate.
In recent years, numerous studies related to myocar-
dial protection have focused especially on ischemic pre-
conditioning (IP), which is a phenomenon whereby brief
periods of ischemia have been shown to protect the
myocardium against a more sustained ischemic insult
[4]. IP improves myocardial function and enhances myo-
cardial tolerance to ischemia-reperfusion injury in part
by triggering endogenous myocardial protection
mechanisms including channels opening, attenuation of
apoptosis, and proteins activation [5-8]. Myocardial pro-
tection against ischemia-reperfusion injury by IP has so
far been well elucidated. It is imperative to dig deep
into the protective role of IP on hypertrophied myocar-
dium for which is more susceptible to ischemia-reperfu-
sion injury than normal myocardium. A few studies
have stated the beneficial effects of IP on hypertrophic
hearts [9], however, the effectiveness and mechanisms
have not yet been clearly demonstrated. Herein, we
investigate the effects of IP on post-ischemic reperfusion
arrhythmias in hypertrophic rabbit hearts.
Methods
Preparation of animal models of myocardial hypertrophy
Healthy New-Zealand rabbits weighing 2.3 ± 0.3 kg were
provided by the Laboratory Animals Center of Sun Yat-
Sen University with the approval of the local ethics
committee. Rabbit models of myocardial hypertrophy
were obtained according to the method by Gillis [10,11].
The rabbits were anesthetized with intravenous (mar-
ginal ear vein) injection of pentobarbital. Under sterile
conditions, a median abdominal incision was made and
the peritoneum was slit to expose the abdominal aorta.
Finally the abdominal aorta was banded with the sup-
port of a hard catheter of 1.6 mm in diameter placed
adjacent to it, to obtain a 40 to 60% stenosis. The
rabbits were raised for six weeks until the day of sacri-
fice and then their hearts were extracted. Ratios of heart
weight to body weight and left ventricular weight to
body weight were calculated. The thickness of left ven-
tricular free wall and interventricular septum was mea-
sured to assess the extent of myocardial hypertrophy.
The heart extracted from healthy rabbit served as a con-
trol. The following criteria were necessary and sufficient
for validating an animal model: (1) a 20% increase in
myocardial weight and thickness, (2) Hematoxylin and
Eosin (H&E) staining outlining hypertrophic myocyte
morphology and alteration of intercalated disk structure
(disruption and disorganization) [12].
Experimental grouping
Thirty-three rabbits of myocardial hypertrophy were
randomly divided into three groups of 11 each: non-
ischemia-reperfusion group (group A), ischemia-reperfu-
s i o ng r o u p( g r o u pB ) ,a n di s c h e m i cp r e c o n d i t i o n i n g
group (group C). Another ten healthy rabbits with nor-
mal myocardium served as the healthy control group.
Ischemia-reperfusion and ischemic preconditioning
During the process, heart rate and mean arterial pres-
sures were recorded. Core body temperature was main-
tained at 37 °C with a thermo heating pad and monitored
with the rectal thermometer. In group B, a 4-0 prolene
suture with needle was passed through the myocardial
surface below the left anterior descending coronary artery
(LAD), and after the attainment of steady state heartbeat
f o r1 5m i n ,a4 0 0U / k gI Vd o s eo fh e p a r i nw a sa d m i n i s -
tered and the LAD was ligated for 15 min to induce
ischemia, with the support of a adjacent catheter. There-
after, the myocardium was reperfused for 90 min. In
group C, the LAD was ligated for three cycles of 5 min
followed by 5-min reperfusion at first for IP, and the rest
of the procedure was identical to that in group B.
Measurement of electrophysiological parameters
After anesthesia, subcutaneous needle electrodes were
inserted in all four limbs to record the surface ECG
(lead II) using the BL-410 bio-functional experimental
system. The ECG was recorded at 20-min intervals for
100 min and the mean value of ECG was used to deter-
mine the arrhythmia score in accordance with a modi-
fied Curtis-Ravingerova scoring system. In group A,
parameters were measured right after the raising period.
With PR or PQ segment as the isopotential line, an ST
segment elevation or depression of at least 0.05 mV was
considered as an abnormal ST-T segment change
related to myocardial ischemia. A change of more than
20% in QRS duration was regarded as remarkable. The
specific scoring was determined as follows: 1 point for
ischemic ST-T segment changes, or supraventricular
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tole; 3 points for coupled ventricular extrasystoles, or
ventricular extrasystoles in the form of bigeminal/tri-
geminal rhythm or more complex rhythm; 4 points for
frequent ventricular extrasystoles (≥5 times/min); 5
points for ventricular tachycardia (VT) lasting less than
30 s; 6 points for VT lasting for at least 30 s; 7 points
for VT with a period of several beats lasting more than
30 s; 8 points for ventricular fibrillation (VF) lasting less
than 5 min; 9 points for VF with a period of several
beats lasting less than 5 min or a VF lasting for at least
5 min; 10 points for VF with a period of several beats
lasting more than 5 min [13].
Determination and measurement of Cx43
Hearts of the rabbit were extracted and dried with a fil-
ter. Specimens of left ventricular myocardium were then
collected in the region supplied by the LAD for HE
staining and cytological examination. Cx43 was detected
and measured using the immunohistofluorescence CY3
Kit (Boster Company). Specimens were frozen in liquid
nitrogen and then fixed with acetone. After washing
with PBS (phosphate-buffered saline), sheep serum was
used to block non-specific antigens. Ten minutes later,
drops of 1:100 dilution of polyclonal Cx43 antibody
(Boshide Company) were added and the preparation was
incubated overnight at 4 °C. After another wash with
PBS, 1:60 dilution of biotin was added, followed by a
second incubation at a stable temperature of 37 °C for
30 min. Drops of 1:120 dilution of fluorescein were then
added. Finally, the preparation was mounted on a slide
and preserved at 4 °C. Analysis and determination of
the expression area and the fluorescence intensity of
Cx43 was performed by confocal laser scanning micro-
scopy. The analysis was completed by the assistance of
the computer software. Acquired images were standar-
dized by ignoring background pixels using the density
slice manipulation. For semiquantitative analysis of
Cx43 expression, the area and intensity of Cx43 immu-
nopositive plaques were measured in a region (350 ×
350 μm
2), randomly selected from different areas.
Statistical analysis
All statistical analyses were performed using SPSS (ver-
sion 11.0). Data are presented as mean ± SD; we used t-
test and one-way analysis of variance to assess differ-
ences between the above-mentioned groups. Statistical
significance was set as 0.05.
Results
Establishment of animal model of myocardial
hypertrophy
Ratios of heart weight to body weight and left ventricu-
lar weight to body weight, as well as left ventricular free
wall thickness and interventricular septal thickness in
group A significantly increase by 29.8%, 31.6%, 22.9%
and 19.5%, respectively, in comparison with the healthy
control group (P < 0.05) (Table 1). In addition, an
obvious hypertrophic HE staining pattern in cardiomyo-
cytes confirmed the successful establishment of animal
model of myocardial hypertrophy.
Microstructure changes in myocardial cells
Observation of healthy myocardium under electron
microscope reveals normal continuous intercalated disks
(Figure 1a). In group A, the discontinuity and disorgani-
zation of intercalated disks can be observed (Figure 1b).
In group B, intercalated disks are disrupted in structure,
and some are partially or even totally ruptured and dis-
integrated (Figure 1c). In group C where the myocar-
dium sustains the same degree of ischemia-reperfusion
injury after IP, structure of intercalated disks are signifi-
cantly less distorted compared with that in group B
(Figure 1d).
Changes in cardioelectrophysiology in hypertrophied
myocardium
In group B and C, ten minutes after LAD ligation, cya-
nosis is visible in the blood-supply region of the LAD.
The ST segment becomes progressively elevated and
stabilized afterwards. Cyanosis disappears and ST seg-
ment elevation resolves during myocardial reperfusion.
In group B, the occurrence of ventricular arrhythmias is
more serious than in group C. In group C, incidences of
ventricular tachycardia, frequent ventricular extrasys-
toles and ST elevation are significantly lower than in
group B (Table 2). The Curtis-Ravingerova score in
group C (2.286 ± 1.380) is significantly lower than in
group B (4.286 ± 1.976) (P < 0.05).
Changes of Cx43 expression in hypertrophied
myocardium
Cx43 expression area in healthy rabbit myocardium is
5325.62 ± 598.90 μm
2 and its fluorescence intensity is
1668.14 ± 231.16. Cx43 expression area in group A
(4232.33 ± 484.43 μm
2)i sr e d u c e db y2 0 . 5 %c o m p a r e d
Table 1 General data of healthy myocardium and
hypertrophied myocardium
Healthy control
group
Hypertrophied
myocardium
HW/BW 1.88 ± 0.16 2.40 ± 0.28**
LVW/BW 1.33 ± 0.12 1.75 ± 0.24*
Thickness of LVFW (mm) 4.20 ± 0.80 5.16 ± 0.75*
Thickness of IVS (mm) 3.90 ± 0.59 4.66 ± 0.66*
*P < 0.05, **P < 0.01, compared with the healthy control group (T test). HW:
heart weight, BW: body weight, LVW: left ventricular weight, LVFW: left
ventricular free wall, IVS: interventricular interventricular septum.
Chen et al. Journal of Cardiothoracic Surgery 2011, 6:80
http://www.cardiothoracicsurgery.org/content/6/1/80
Page 3 of 6with the healthy control group, but there is no signifi-
cant difference in the fluorescence intensity (1599.43 ±
246.52). In group B, Cx43 expression area (1443.35 ±
231.46 μm
2) decreases by 65.9% (P < 0.05) and the
fluorescence intensity (1217.14 ± 162.44) is reduced by
23.9%, compared with group A (P < 0.05). In group C,
Cx43 expression area (1911.72 ± 214.77 μm
2) increases
by 32.5% (P < 0.05) in comparison to that in group B,
but is reduced by 54.8% (P < 0.05) when compared with
group A. There is no significant difference in the fluor-
escence intensity between group B and group C
(1301.00 ± 334.88). Curtis-Ravingerova score (Y) is
significantly negatively correlated with Cx43 expression
area (X) (r = -0.683, P < 0.05; regression equation Y =
10.137 - 4.08 × 10
-3X, P < 0.05). Curtis-Ravingerova
score and Cx43 fluorescence intensity are not correlated
(Figure 2).
Discussion
It is known that arrhythmia occurrence increases with
the susceptibility of hypertrophied myocardium to ische-
mia-reperfusion injury during open heart surgeries
[9,14,15]. Pathological changes in cell structure and
metabolism of hypertrophied myocardium decrease its
tolerance to ischemia-reperfusion injury. This happens
especially in subjects with preoperative cardiac insuffi-
ciency, in which arrhythmias are more easily induced by
stress and injury from intraoperative hypothermic cardi-
oplegia and ischemia-reperfusion [16].
Various mechanisms of reperfusion arrhythmias in
hypertrophied myocardium have been proposed [17,18].
In this study, intercalated disks of myocardial cells in
hypertrophied rabbit myocardium appear disrupted and
some partially or even totally ruptured and disintegrated
after ischemia-reperfusion. Accordingly, ventricular
arrhythmia occurrence increases with the degree of
structural damage in the intercalated disks.
Applying IP to hypertrophied hearts is still a matter of
controversy, as protective efficacy of IP has not yet been
proved for hypertrophied myocardium. Some reports
s u g g e s t e dt h a tI Pi t s e l fd o e s n ’t show direct antiarrhyth-
mic effects, but delays or alleviates arrhythmias by redu-
cing the necrotic area and delaying myocytes necrosis
[19]. It has also been reported that the role of IP in the
Figure 1 TEM micrographs of myocardium.( a )t h eh e a l t h y
group; (b) group A; (c) group B; (d) group C.
Table 2 Influence of ischemic preconditioning on
arrhythmia incidence of hypertrophied myocardium
Incidence (%) Ischemia-
reperfusion
group
Ischemic
preconditioning
group
Ventricular tachycardia 33.3 11.1*
Ventricular extrasystole 55.6 55.6
Frequent Ventricular extrasystole 22.2 11.1*
ST segment elevation > 0.05 mV 77.8 55.6*
QRS amplitude increase > 20% 55.6 66.7
*P < 0.05, compared with ischemia-reperfusion group (T test).
Figure 2 Cx43 expression area and fluorescence intensity in
rabbit myocardium measured by immunohistofluorescence.* P
< 0.05, compared with the control group; **P < 0.05, compared
with group A;
#P < 0.05, compared with group B (one-way ANOVA).
Control: healthy rabbit myocardium, Group A: non-ischemia-
reperfusion group of hypertrophied myocardium, Group B: ischemia-
reperfusion group of hypertrophied myocardium, Group C: ischemic
preconditioning group of hypertrophied myocardium.
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change electrophysiological properties of myocardial tis-
sues [13,20]. In this study, lower incidences of ventricular
tachycardia and frequent ventricular extrasystoles are
observed in hypertrophic rabbit hearts with IP before
ischemia-reperfusion injury. Moreover, Curtis-Ravinger-
ova score is reduced by approximately 50% and Cx43
expression area increases by over 30%. Curtis-Ravinger-
ova arrhythmia score is negatively correlated with Cx43
expression area. There is no significant difference in
Cx43 fluorescence intensity. Our results suggest that IP
may reduce arrhythmia occurrence after ischemia-reper-
fusion by maintaining the spatial distribution of Cx43-
based gap junction channels, and hence possibly protect-
ing electrophysiological properties of myocardial tissues.
In addition, Cx43 expression area, an important archi-
tectural factor related to post-ischemic reperfusion
arrhythmias in hypertrophied myocardium, is reduced
by 20.5% compared with normal myocardium. However,
there is no significant difference in fluorescence inten-
sity. Cx43 expression area and fluorescence intensity in
hypertrophied myocardium after ischemia-reperfusion
are reduced by 65.9% and 23.9%, respectively, compared
with non-ischemia-reperfusion hypertrophied myocar-
dium. Similar results have been reported by other
studies [21], suggesting the existence of an electrophy-
siopathological basis of arrhythmias after ischemia-
reperfusion in hypertrophied hearts, which may be
related to the fact that chronic myocardial hypertrophy
leads to electrophysiological-related microstructural
changes. These microstructural changes may be asso-
ciated with the decline in Cx43 expression area, as well
as the diminution in the number of low-resistance chan-
nels mainly composed of Cx43. Therefore, the slow
myocardial electrical conduction and the prolonged car-
diac repolarization make hypertrophied myocardium
more vulnerable [22]. This is one of the risk factors for
post-ischemic arrhythmias in hypertrophic hearts. The
down-regulation of the fluorescence intensity of Cx43
after ischemia-reperfusion in hypertrophied myocardium
suggests an alteration of the permeability of gap junc-
tion channels, which initiate action potential and possi-
ble after-depolarization activity and thus constitute
another pathway leading to post-ischemic arrhythmias.
Results from Cx43 fluorescence intensity measure-
ments suggest that the permeability of Cx43-formed gap
junction channel is less affected by IP. In recent years,
the activation of protein kinase (PKC) has been reported
as an important element in myocardial protection with
IP. It functions by promoting phosphorylation of a num-
ber of effective myocardial proteins, including connexin
molecules, through signal transduction system [23-27,
29]. Effective distribution of Cx43 molecules and the
status of Cx43 phosphorylation are determinant factors
of conductance and permeability of gap junction chan-
nels [30].
Conclusions
Our study suggests that the incidence of ischemia/reper-
fusion-induced arrhythmias in hypertrophic rabbit hearts
decreases after IP, which plays an important antiarrhyth-
mic role in hypertrophied myocardium during ischemia-
reperfusion by maintaining the integrity of its electro-
physiological features such as the up-regulation in Cx43
expression area. As it is known that Cx43 can quickly
translocate between several organelles under pathologic
conditions such as ischemia, the changes in membrane
connexin or gap junction plaque density should be
further elucidated by other techniques such as RT-PCR,
which will be reported in future work.
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